What question did this study set out to answer?

The review aims to summarize advancements in the understanding of the genetic factors related to metabolic dysfunction-associated steatotic liver disease (MASLD).

November 10, 2025International Journal of Molecular SciencesOpen Access

Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver Disease

View Full Paper

Ask AI

Bookmark

Authors

PSPeter Saliba‐Gustafsson JHJennifer Härdfeldt MPMatteo Pedrelli

Discussion

Member takes

Implication

Review reveals genetic architecture and potential of genomic methods for precision medicine in MASLD.

Key Points

The review aims to summarize advancements in the understanding of the genetic factors related to metabolic dysfunction-associated steatotic liver disease (MASLD).
Review of recent genome-wide association studies (GWAS) related to MASLD
Assessment of next-generation sequencing findings for rare and protective variants
Discussion of polygenic risk scores for stratifying MASLD risk
Identification of risk variants in genes like PNPLA3, TM6SF2, GCKR, and MBOAT7
Insights into the use of polygenic risk scores for disease management
Recognition of significant translational gaps in utilizing genomic findings for clinical applications

Cite This Study

Saliba‐Gustafsson et al. (2025) studied this question.

synapsesocial.com/papers/69253a16c0ce034ddc356e13 https://doi.org/10.3390/ijms262210881

View Full Paper

Ask AI

Bookmark

Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver Disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver Disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider